J&J Initiates Second Global Phase 3 Clinical Trial of its Janssen COVID-19 Vaccine Candidate Read more
Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2 Read more
Brazil’s National Health Surveillance Agency Authorizes Resumption of the Phase III Clinical Trial of CoronaVac Read more
Sagent Pharmaceuticals Launches Phase 2 Trial to Evaluate Camostat Mesilate for COVID-19 Treatment Read more
Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab Read more